OverviewZogenix, Inc. (Nasdaq: ZGNX) is a pharmaceutical company committed to developing and commercializing CNS therapies that address specific clinical needs for people living with orphan and other CNS disorders who need innovative treatment alternatives to improve their daily functioning.
NASDAQ | ZGNX (Common Stock)
$12.15 - 0.2
Data as of 12/09/16 4:00 p.m. ET
Data provided by Nasdaq. Minimum 15 minutes delayed.
Investor Events More
Tuesday, November 29, 2016
Zogenix, Inc. at Oppenheimer Life Sciences Summit 2016
Tuesday, November 15, 2016 3:45 p.m. ET
Zogenix, Inc. at Stifel 2016 Healthcare Conference